Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefpwel S Injection
Cefpwel S Injection is a reliable solution for managing severe bacterial infections. With Cefpirome 1g and Sulbactam 0.5g, this combination offers enhanced antibacterial activity and robust protection against resistant pathogens, ensuring effective treatment outcomes in hospitalized patients.
Uses of Cefpwel S Injection
Treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP)
Management of complicated intra-abdominal infections (cIAI)
Effective against complicated urinary tract infections (UTIs)
Useful in treating skin and soft tissue infections caused by resistant bacteria
Reliable for managing sepsis and bloodstream infections
Benefits of Cefpwel S Injection
Broad-spectrum activity, including beta-lactamase-producing bacteria
Enhanced efficacy against resistant pathogens
Rapid bacterial clearance, improving patient recovery times
Clinically proven safety and effectiveness in critical infections
Offers a trusted treatment option for serious hospital-acquired infections
Mechanism of Action of Cefpwel S Injection
Cefpirome inhibits bacterial cell wall synthesis, leading to bacterial cell death.
Sulbactam inhibits beta-lactamase enzymes, preserving Cefpirome’s antibacterial potency.
Together, they provide comprehensive coverage, ensuring reliable bacterial eradication.
For best results, use Cefpwel S Injection as directed by your healthcare provider. Ensure proper preparation and administration under medical supervision. Store appropriately and follow all instructions for safe and effective use.